BioAtla and GATC Health announce $40 million SPV transaction to advance ozuriftamab vedotin into a registrational trial for 2L+ OPSCC: San Diego Saturday, January 3, 2026, 18:00 H ...
The ROR family of proteins includes ROR1 and ROR2 – receptor tyrosine kinases. ROR1 is especially interesting to pharmacologists as it has only been observed in cancerous and embryonic cells, and ...
The False Son is a unique Risk of Rain 2 character who makes frequent use of both melee and ranged attacks. He can be a little confusing to use at first, but once players get the groove of his ...
The Engineer is one of the many classes you can select in Risk of Rain 2. This class emphasizes bombastic damage and support abilities, making him an invaluable asset to any team. Given the Engineer’s ...
The mechanism underlying astrocyte-mediated restoration of brain tissue after an injury has now been pinpointed by a team of researchers. This could lead to new treatments that encourage regeneration ...
BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback